This inventor holds 4 USPTO granted patents, plus 1 CIPO patent and 3 EPO patents. Top assignee: Sanofi. Active years: 2017-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2026
Title: Paul Ferrari: Innovator in Cancer Treatment
Introduction
Paul Ferrari is a notable inventor based in Paris, France. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for cancer treatment. With a total of three patents to his name, Ferrari's work is paving the way for innovative therapeutic solutions.
Latest Patents
Ferrari's latest patents include groundbreaking work on Anti-CEACAM5 antibodies and their uses. These patents disclose antibodies that bind to human CEACAM5 proteins, along with isolated nucleic acids, vectors, and host cells that contain sequences encoding these antibodies. Additionally, the patents describe immunoconjugates that link these antibodies to growth-inhibitory agents, as well as pharmaceutical compositions that incorporate the antibodies or immunoconjugates. The applications of these innovations are primarily focused on the treatment of cancer and diagnostic purposes.
Career Highlights
Throughout his career, Paul Ferrari has been associated with Sanofi, a leading global healthcare company. His work at Sanofi has allowed him to collaborate with other experts in the field and contribute to significant advancements in cancer treatment.
Collaborations
Ferrari has worked alongside notable colleagues such as Pierre-Francois Berne and Francis Blanche. These collaborations have fostered a productive environment for innovation and have led to the successful development of new therapeutic approaches.
Conclusion
In summary, Paul Ferrari
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile